Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

98
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
98
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

57
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
57
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

104
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
104
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

79
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
79

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and therapeutic treatment methods for intrathoracic extrapulmonary lipomas.

Nigerian journal of clinical practice·2020
Same author

Metastatic lung cancer associated with Warthin's tumour.

Nigerian journal of clinical practice·2019
Same author

Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.

Bratislavske lekarske listy·2018
Same author

Multiple Cerebral Emboli in a Homozygous b-Thalassaemia Patient Due to Factor V 1299 (His-Arg) 4070 A-G Mutation.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2016
Same author

Homozygous ß-Thalassemia (FCS8-AA) and Hereditary Spherocytosis in the Same Patient.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2016
Same author

Hemoglobin Lepore Boston in a Turkish Family.

Turkish journal of haematology : official journal of Turkish Society of Haematology·2016

Related Experiment Video

Updated: Mar 20, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

p53 Gene Polymorphisms in the Turkish Population.

N Akar, E Akar, Ş Cin

    Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
    |June 7, 2016
    PubMed
    Summary

    This study investigated variations in the p53 gene within a healthy Turkish population. Researchers identified specific restriction fragment length polymorphisms (RFLPs) and their frequencies, providing insights into genetic diversity.

    Area of Science:

    • Molecular Biology
    • Human Genetics
    • Population Studies

    Background:

    • The p53 gene is a critical tumor suppressor, and its variations can influence cancer risk.
    • Understanding genetic polymorphisms in diverse populations is essential for personalized medicine and disease association studies.
    • Restriction Fragment Length Polymorphisms (RFLPs) are valuable tools for analyzing genetic variation.

    Purpose of the Study:

    • To characterize specific RFLPs within the p53 gene in a healthy Turkish cohort.
    • To determine the frequencies and heterozygosity rates of identified p53 gene variations.

    Main Methods:

    • Analysis of RFLPs at specific loci on the p53 gene, including exon 4 (CD 47), exon 6 (CD 213), and intron 6 (A-G).
    • Genotyping of a healthy Turkish population to identify the presence and frequency of these RFLPs.

    More Related Videos

    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
    04:56

    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

    Published on: December 30, 2025

    311
    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
    06:21

    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

    Published on: May 10, 2024

    1.4K

    Related Experiment Videos

    Last Updated: Mar 20, 2026

    Yeast As a Chassis for Developing Functional Assays to Study Human P53
    14:57

    Yeast As a Chassis for Developing Functional Assays to Study Human P53

    Published on: August 4, 2019

    10.1K
    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
    04:56

    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

    Published on: December 30, 2025

    311
    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
    06:21

    Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

    Published on: May 10, 2024

    1.4K
  • Calculation of allele frequencies and heterozygosity rates for the observed polymorphisms.

    • Main Results:

    • The CD 47 (C-T) RFLP was absent in the studied population.
    • The CD 213 (G) RFLP was rare, with a frequency of 0.0114.
    • The Int 6 A/G alteration showed a frequency of 0.70 for the 'G' allele, with a heterozygosity rate of 32.72%.

    Conclusions:

    • The study successfully characterized p53 gene RFLPs in a Turkish population, revealing specific allele frequencies.
    • The observed RFLP patterns contribute to the understanding of p53 genetic diversity in this demographic.
    • These findings can serve as a baseline for future genetic association studies involving the p53 gene in Turkish individuals.